To Assess the Safety and Efficacy of SP-002 with Vismodegib for the Treatment of Locally Advanced Basal Cell Carcinoma
for Basal Cell Carcinoma
10 locations incl. Phoenix
Sponsor: Stamford Pharmaceuticals, Inc.
Sex: All·Age: 18+
Code: NCT06344052·Phase 2·Recruiting